OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy
Valentina Pegoraro, Paola Cudia, Alfonc Baba, et al.
Neurological Sciences (2020) Vol. 41, Iss. 10, pp. 2953-2960
Closed Access | Times Cited: 17
Valentina Pegoraro, Paola Cudia, Alfonc Baba, et al.
Neurological Sciences (2020) Vol. 41, Iss. 10, pp. 2953-2960
Closed Access | Times Cited: 17
Showing 17 citing articles:
The elusive role of myostatin signaling for muscle regeneration and maintenance of muscle and bone homeostasis
Akash Mitra, Rizwan Qaisar, Bipasha Bose, et al.
Osteoporosis and Sarcopenia (2023) Vol. 9, Iss. 1, pp. 1-7
Open Access | Times Cited: 10
Akash Mitra, Rizwan Qaisar, Bipasha Bose, et al.
Osteoporosis and Sarcopenia (2023) Vol. 9, Iss. 1, pp. 1-7
Open Access | Times Cited: 10
Circulating Biomarkers in Neuromuscular Disorders: What Is Known, What Is New
Andrea Barp, Amanda Ferrero, Silvia Casagrande, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1246-1246
Open Access | Times Cited: 19
Andrea Barp, Amanda Ferrero, Silvia Casagrande, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1246-1246
Open Access | Times Cited: 19
The Biomarker Potential of miRNAs in Myotonic Dystrophy Type I
Emma Koehorst, Alfonsina Ballester‐Lopez, Virginia Arechavala‐Gomeza, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3939-3939
Open Access | Times Cited: 19
Emma Koehorst, Alfonsina Ballester‐Lopez, Virginia Arechavala‐Gomeza, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3939-3939
Open Access | Times Cited: 19
Epigenetics of neuromuscular disorders
Fabio Coppedè
Epigenomics (2020) Vol. 12, Iss. 23, pp. 2125-2139
Closed Access | Times Cited: 18
Fabio Coppedè
Epigenomics (2020) Vol. 12, Iss. 23, pp. 2125-2139
Closed Access | Times Cited: 18
Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
Irene González-Martínez, Estefanía Cerro-Herreros, Nerea Moreno, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 34, pp. 102024-102024
Open Access | Times Cited: 6
Irene González-Martínez, Estefanía Cerro-Herreros, Nerea Moreno, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 34, pp. 102024-102024
Open Access | Times Cited: 6
Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1
Jie Liu, Zhen‐Ni Guo, Xiu‐Li Yan, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 13
Jie Liu, Zhen‐Ni Guo, Xiu‐Li Yan, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 13
Epigenetics of Myotonic Dystrophies: A Minireview
Virginia Veronica Visconti, Federica Centofanti, Simona Fittipaldi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12594-12594
Open Access | Times Cited: 11
Virginia Veronica Visconti, Federica Centofanti, Simona Fittipaldi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12594-12594
Open Access | Times Cited: 11
miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1
Demetris Koutalianos, Andrie Koutsoulidou, Chrystalla Mytidou, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 23, pp. 169-183
Open Access | Times Cited: 8
Demetris Koutalianos, Andrie Koutsoulidou, Chrystalla Mytidou, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 23, pp. 169-183
Open Access | Times Cited: 8
Effectiveness of conservative non-pharmacological interventions in people with muscular dystrophies: a systematic review and meta-analysis
Enza Leone, Anand Pandyan, Alison Rogers, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023), pp. jnnp-331988
Open Access | Times Cited: 2
Enza Leone, Anand Pandyan, Alison Rogers, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023), pp. jnnp-331988
Open Access | Times Cited: 2
Combinatorial therapies for rescuing myotonic dystrophy type 1 skeletal muscle defects
Aymeric Ravel‐Chapuis, Bernard J. Jasmin
Trends in Molecular Medicine (2022) Vol. 28, Iss. 6, pp. 439-442
Closed Access | Times Cited: 4
Aymeric Ravel‐Chapuis, Bernard J. Jasmin
Trends in Molecular Medicine (2022) Vol. 28, Iss. 6, pp. 439-442
Closed Access | Times Cited: 4
microRNA-mRNA expression profiles in the skeletal muscle of myotonic dystrophy type 1
Mao Li, Yifan Li, Zhanjun Wang, et al.
Neurological Research (2024) Vol. 46, Iss. 7, pp. 613-625
Closed Access
Mao Li, Yifan Li, Zhanjun Wang, et al.
Neurological Research (2024) Vol. 46, Iss. 7, pp. 613-625
Closed Access
Automatic Text-Mining Approach to Identify Molecular Target Candidates Associated with Metabolic Processes for Myotonic Dystrophy Type 1
Dhvani H. Kuntawala, Filipa Martins, Rui Vitorino, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 2283-2283
Open Access | Times Cited: 1
Dhvani H. Kuntawala, Filipa Martins, Rui Vitorino, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 2283-2283
Open Access | Times Cited: 1
The role of microRNAs in muscle wasting and recovery during critical illness: a systematic review
María Borja-Gonzalez, Sarah M. Coyne, Sarah Fagan, et al.
JCSM Rapid Communications (2023) Vol. 6, Iss. 2, pp. 68-80
Open Access | Times Cited: 1
María Borja-Gonzalez, Sarah M. Coyne, Sarah Fagan, et al.
JCSM Rapid Communications (2023) Vol. 6, Iss. 2, pp. 68-80
Open Access | Times Cited: 1
The effect of TRX, combined with vibration training, on BMI, the body fat percentage, myostatin and follistatin, the strength endurance and layup shot skills of female basketball players
Ahmed K. Hassan, Abdulmalek K. Bursais, Sobhi Noureldin Ata, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20844-e20844
Open Access | Times Cited: 1
Ahmed K. Hassan, Abdulmalek K. Bursais, Sobhi Noureldin Ata, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20844-e20844
Open Access | Times Cited: 1
W zdrowiu i chorobie – mikroRNA w funkcjonowaniu mięśni szkieletowych
Karolina Romańczuk, Bartosz Mierzejewski, Zuzanna Michalska, et al.
Postępy Biochemii (2022)
Open Access | Times Cited: 1
Karolina Romańczuk, Bartosz Mierzejewski, Zuzanna Michalska, et al.
Postępy Biochemii (2022)
Open Access | Times Cited: 1
Circulating non-coding RNAs as biomarkers in coronary artery disease
Aleksa Petković, Sanja Erceg, Jelena Munjas, et al.
Arhiv za farmaciju (2022) Vol. 72, Iss. 2, pp. 149-165
Open Access | Times Cited: 1
Aleksa Petković, Sanja Erceg, Jelena Munjas, et al.
Arhiv za farmaciju (2022) Vol. 72, Iss. 2, pp. 149-165
Open Access | Times Cited: 1
El papel de los RNAs no-codificantes en la patogénesis de la distrofia miotónica tipo 1
Nadia Mireya Murillo-Melo, Fabiola Vianet Borbolla-Jiménez, Óscar Hernández‐Hernández, et al.
Investigación en Discapacidad (2022) Vol. 8, Iss. 1, pp. 29-38
Open Access
Nadia Mireya Murillo-Melo, Fabiola Vianet Borbolla-Jiménez, Óscar Hernández‐Hernández, et al.
Investigación en Discapacidad (2022) Vol. 8, Iss. 1, pp. 29-38
Open Access
